hero-banner-image

TOGETHER, WE'VE GOT THIS.

Patients Can't Wait. Neither Can We.™

Learn More

A Transformational Approach to Clinical Trials

LabCorp Transforms the Clinical Trial Experience to Streamline its Drug Development Process

Company goes beyond decentralized clinical trials to deliver seamless tech-enabled, patient-centric enterprise solutions. LabCorp now offers a comprehensive and fully integrated patient, site, and customer experience for DCTs.

A NEW AND INNOVATIVE APPROACH TO RECRUITMENT OF ONCOLOGY PATIENTS

Covance and Tempus Have Joined Forces to Accelerate Patient Recruitment in Biomarker-Driven Studies

We are expanding our patient-centric approach to recruitment by incorporating the Tempus Integrated Molecular Evaluation (TIME) Trial™ Program. Learn more about how our combined recruitment capabilities can screen and match patients to biomarker trials to open a site in as few as 10 days.

Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

LabCorp has announced that Covance has completed the transaction to acquire snapIoT, the fastest growing platform as a service provider of mobile-connected self-service platform solutions. This acquisition enables Covance to offer highly configurable and inter-operable patient centric solutions that enable remote participation in clinical trials, reduce patient burden while speeding implementation and improving data quality.

We’re in this together

COVID-19

Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.

News

Covance Announces Acquisition of GlobalCare Clinical Trials, LLC

LabCorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the Covance DCTs offering into global markets and help us meet your growing demand for patient-centric trial designs.  

Covance Innovation

Patients can’t wait. And neither can we™

The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease…to improve quality of life. And it’s our mission to help speed that process. What matters is not “how it’s always been done,” but how it can be done now. Better. And Faster. Through new approaches explored, ideas perfected, and transformational thinking. 

#COVANCEPOTENTIAL

It's not just a job. To us, it's personal.

Covance, the drug development business of LabCorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.
 

Covance by the Numbers

Annual Encounters 160M Patients
Supports Clinical Trials in 100+ Countries
Collaborated on 100% Novel Oncology Drugs
Helped Develop 86% Rare & Orphan Drugs

Contributed in the development of all the current top 50 drugs on the market

Covance Insights

COVID-19: vaccine innovation and safety at pandemic speed
COVID-19: vaccine innovation and safety at pandemic speed
Blogs
The global spread of COVID-19 and its great impact on the health and wellbeing of our population has imposed a race to develop an effective vaccine at unprecedented speed. A development process that usually spans several years is being compressed into one year - or less. Safety is a vital part of this process, and so we identified and discussed several key factors and considerations around safety in vaccine development. This article provides a synopsis of our insights.
Read More
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
White Papers
The current regulatory environment can help support sponsors with the complex efforts involved in pediatric oncology drug development, as regulatory agencies and legislative acts have helped encourage, incentivize or even require the conduct of pediatric trials in other indications. This white paper provides a brief history of how pediatric cancer treatments have progressed, outlines how regulatory changes have impacted the field of pediatric drug development and provides guidance on applying current regulations, such as the RACE for Children Act which is focused on pediatric oncology. This change should serve to enhance an inclusive regulatory strategy for oncologic drug development.
Read More
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Brochures
Craft the optimal preclinical strategy by collaborating with our medical device development specialists. Then access the preclinical resources necessary to make your initial development stage easier. Whether you are exploring a promising device concept, initiating a comprehensive testing plan or conducting a single study, Covance Medical Device and Diagnostic Solutions can help you prove out your device in its earliest stage of development.
Read More
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
Case Studies
A top-5 pharmaceutical company partnered with Covance to provide field reimbursement management (FRM) services for their autoimmune infusion therapy program. Learn more about how Covance played a critical role in facilitating enrollment and stakeholder satisfaction.
Read More

Stay up to date with the latest news from Covance

Subscribe Now

Learn More